Wednesday, 22 September, 2021

India, UK to conduct clinical trials of Ashwagandha for Covid recovery

  • Sun Online Desk
  • 1st August, 2021 05:16:14 PM
  • Print news
India, UK to conduct clinical trials of Ashwagandha for Covid recovery

Popular News


The AYUSH Ministry will conduct a joint study on Ashwagandha for promoting recovery from COVID-19 with the UK London School of Hygiene and Tropical Medicine (LSHTM).

The All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of AYUSH, and LSHTM recently signed a memorandum of understanding to conduct clinical trials of Ashwagandha on 2,000 people in three UK cities — Leicester, Birmingham, and London (Southall and Wembley), the ministry said in a statement.

Ashwagandha (withania somnifera), commonly known as ‘Indian winter cherry,’ is a traditional herb that boosts energy, reduces stress and makes the immune system stronger. It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile, it said., according to media report.

According to AIIA Director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator – International Projects, the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

“For three months, one group of 1,000 participants will be administered Ashwagandha (AG) tablets while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group’s treatment in a double-blind trial,” Dr Nesari said in the statement.

The participants will have to take the 500 mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events will be carried out.